Disclosures for "Severity Variant rs10191329 has no Effect on Prognostic Factors, Serum GFAP Levels and Cognitive Impairment in Turkish Patients With Multiple Sclerosis"
-
Dr. Kaya Dogu has nothing to disclose.
-
Dr. Purtuloglu has nothing to disclose.
-
Prof. Terzi has received research support from The Scientific and Technological Research Council of Türkiye (TÜBITAK).
-
Prof. Celik has nothing to disclose.
-
The institution of Prof. Can Demirdögen has received research support from TÜBITAK. Prof. Can Demirdögen has received personal compensation in the range of $500-$4,999 for serving as a Reviewer, Panelist, Project monitor with TÜBITAK. Prof. Can Demirdögen has received personal compensation in the range of $0-$499 for serving as a Reviewer, Moderator with TÜSEB. Prof. Can Demirdögen has a non-compensated relationship as a Associate Editor with Turkish Journal of Biochemistry that is relevant to AAN interests or activities. Prof. Can Demirdögen has a non-compensated relationship as a Member with Turkish Society of Biochemistry that is relevant to AAN interests or activities. Prof. Can Demirdögen has a non-compensated relationship as a Member with Medical Biology and Genetics Society that is relevant to AAN interests or activities.
-
Dr. Derle ciftci has nothing to disclose.
-
Munire Kilinc Toprak has nothing to disclose.